BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 26162974)

  • 1. Melt-Extruded Eudragit® FS-Based Granules for Colonic Drug Delivery.
    Zhang F
    AAPS PharmSciTech; 2016 Feb; 17(1):56-67. PubMed ID: 26162974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicochemical properties and mechanisms of drug release from melt-extruded granules consisting of chlorpheniramine maleate and Eudragit FS.
    Zhang F
    Drug Dev Ind Pharm; 2016; 42(4):563-71. PubMed ID: 26065535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties of hot-melt extruded tablet formulations for the colonic delivery of 5-aminosalicylic acid.
    Bruce LD; Shah NH; Malick AW; Infeld MH; McGinity JW
    Eur J Pharm Biopharm; 2005 Jan; 59(1):85-97. PubMed ID: 15567305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro dissolution studies of sodium diclofenac granules coated with Eudragit L-30D-55 by fluidized-bed system.
    Silva OS; Souza CR; Oliveira WP; Rocha SC
    Drug Dev Ind Pharm; 2006 Jul; 32(6):661-7. PubMed ID: 16885121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Permeability and swelling studies on free films containing inulin in combination with different polymethacrylates aimed for colonic drug delivery.
    Akhgari A; Farahmand F; Afrasiabi Garekani H; Sadeghi F; Vandamme TF
    Eur J Pharm Sci; 2006 Jul; 28(4):307-14. PubMed ID: 16713201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The manufacture and characterisation of hot-melt extruded enteric tablets.
    Andrews GP; Jones DS; Diak OA; McCoy CP; Watts AB; McGinity JW
    Eur J Pharm Biopharm; 2008 May; 69(1):264-73. PubMed ID: 18164604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid-state plasticization of an acrylic polymer with chlorpheniramine maleate and triethyl citrate.
    Zhu Y; Shah NH; Malick AW; Infeld MH; McGinity JW
    Int J Pharm; 2002 Jul; 241(2):301-10. PubMed ID: 12100857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and evaluation of colon adhesive pellets of 5-aminosalicylic acid.
    Xu M; Sun M; Qiao H; Ping Q; Elamin ES
    Int J Pharm; 2014 Jul; 468(1-2):165-71. PubMed ID: 24746693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coated hard capsules as the pH-dependent drug transport systems to ileo-colonic compartment.
    Dvořáčková K; Rabišková M; Muselík J; Gajdziok J; Bajerová M
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1131-40. PubMed ID: 21417619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eudragit(®) RS PO/RL PO as rate-controlling matrix-formers via roller compaction: Influence of formulation and process variables on functional attributes of granules and tablets.
    Dave VS; Fahmy RM; Bensley D; Hoag SW
    Drug Dev Ind Pharm; 2012 Oct; 38(10):1240-53. PubMed ID: 22257339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery.
    Ibekwe VC; Fadda HM; Parsons GE; Basit AW
    Int J Pharm; 2006 Feb; 308(1-2):52-60. PubMed ID: 16356670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of lidocaine forms (salt vs. freebase) on properties of drug-eudragit® L100-55 extrudates prepared by reactive melt extrusion.
    Liu X; Ma X; Kun E; Guo X; Yu Z; Zhang F
    Int J Pharm; 2018 Aug; 547(1-2):291-302. PubMed ID: 29883791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel pH- and time-based multi-unit potential colonic drug delivery system. I. Development.
    Gupta VK; Beckert TE; Price JC
    Int J Pharm; 2001 Feb; 213(1-2):83-91. PubMed ID: 11165096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
    Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO
    AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties of melt extruded enteric matrix pellets.
    Schilling SU; Shah NH; Waseem Malick A; McGinity JW
    Eur J Pharm Biopharm; 2010 Feb; 74(2):352-61. PubMed ID: 19782133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of drug-containing spherical pellets produced by a hot-melt extrusion and spheronization process.
    Young CR; Koleng JJ; McGinity JW
    J Microencapsul; 2003; 20(5):613-25. PubMed ID: 12909545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a novel tablet-in-capsule formulation of mesalamine for inflammatory bowel disease.
    Patel MM; Amin AF
    Pharm Dev Technol; 2013; 18(2):390-400. PubMed ID: 22304735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel application of hot-melt extrusion for the preparation of monolithic matrices containing enteric-coated particles.
    Schilling SU; McGinity JW
    Int J Pharm; 2010 Nov; 400(1-2):24-31. PubMed ID: 20727956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicochemical characterization and mechanisms of release of theophylline from melt-extruded dosage forms based on a methacrylic acid copolymer.
    Young CR; Dietzsch C; Cerea M; Farrell T; Fegely KA; Rajabi-Siahboomi A; McGinity JW
    Int J Pharm; 2005 Sep; 301(1-2):112-20. PubMed ID: 16055285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.